Kymera Therapeutics, Inc. (KYMR)
117.01
-0.56
(-0.48%)
USD |
NASDAQ |
Oct 28, 09:40
Kymera Therapeutics Market Cap : 9.687B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 9.733B |
| October 26, 2026 | 9.507B |
| October 23, 2026 | 9.170B |
| October 22, 2026 | 9.177B |
| October 21, 2026 | 9.324B |
| October 20, 2026 | 9.393B |
| October 19, 2026 | 8.947B |
| October 16, 2026 | 8.675B |
| October 15, 2026 | 8.953B |
| October 14, 2026 | 8.844B |
| October 13, 2026 | 8.832B |
| October 12, 2026 | 9.279B |
| October 09, 2026 | 9.305B |
| October 08, 2026 | 9.049B |
| October 07, 2026 | 8.970B |
| October 06, 2026 | 8.774B |
| October 05, 2026 | 9.094B |
| October 02, 2026 | 8.891B |
| October 01, 2026 | 9.117B |
| September 30, 2026 | 9.255B |
| September 29, 2026 | 9.149B |
| September 28, 2026 | 9.272B |
| September 25, 2026 | 9.268B |
| September 24, 2026 | 9.588B |
| September 23, 2026 | 9.560B |
| Date | Value |
|---|---|
| September 22, 2026 | 10.11B |
| September 21, 2026 | 9.742B |
| September 18, 2026 | 9.748B |
| September 17, 2026 | 9.809B |
| September 16, 2026 | 9.631B |
| September 15, 2026 | 9.367B |
| September 14, 2026 | 9.490B |
| September 11, 2026 | 9.517B |
| September 10, 2026 | 9.686B |
| September 09, 2026 | 9.556B |
| September 08, 2026 | 9.642B |
| September 04, 2026 | 9.719B |
| September 03, 2026 | 9.709B |
| September 02, 2026 | 9.821B |
| September 01, 2026 | 9.856B |
| August 31, 2026 | 9.836B |
| August 28, 2026 | 9.781B |
| August 27, 2026 | 9.954B |
| August 26, 2026 | 10.39B |
| August 25, 2026 | 10.48B |
| August 24, 2026 | 10.02B |
| August 21, 2026 | 9.918B |
| August 20, 2026 | 10.06B |
| August 19, 2026 | 10.54B |
| August 18, 2026 | 10.05B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.728B |
| Twist Bioscience Corp. | 10.55B |
| Beam Therapeutics, Inc. | 2.613B |
| Arrowhead Pharmaceuticals, Inc. | 8.292B |
| Oncolytics Biotech, Inc. | 56.83M |
Market Cap Related Metrics
| PS Ratio | 103.90 |
| Price to Book Value | 6.418 |
| Price | 117.01 |
| Earnings Yield | -2.77% |